Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units
PHASE4CompletedINTERVENTIONAL
Enrollment
9
Participants
Timeline
Start Date
January 31, 2013
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Conditions
Initial Phase of Severe Sepsis and Septic Shock
Interventions
DRUG
Meropenem
Trial Locations (1)
90110
Prince of Songkla University, Hat Yai
All Listed Sponsors
collaborator
Prince of Songkla University
OTHER
lead
Sutep Jaruratanasirikul
OTHER
NCT02213796 - Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units | Biotech Hunter | Biotech Hunter